Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Alen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Addiction Biology|August 21, 2020
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinkingAntonio Ballesta, Francisco Alen, Laura Orio, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2016
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampusEduardo Blanco, Pablo Galeano, Ana Palomino, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 9, 2019
Bupropion, a possible antidepressant without negative effects on alcohol relapseAntonio Ballesta, Laura Orio, Rocío Arco, et al.
Neuropharmacology|March 2, 2019
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressantsPablo Romero-Sanchiz, Raquel Nogueira-Arjona, Antoni Pastor, et al.
Biochemical Pharmacology|September 10, 2018
PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat modelsFrancisco Alen, Juan Decara, Gloria Brunori, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Addiction Biology|August 21, 2020
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinkingAntonio Ballesta, Francisco Alen, Laura Orio, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2016
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampusEduardo Blanco, Pablo Galeano, Ana Palomino, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 9, 2019
Bupropion, a possible antidepressant without negative effects on alcohol relapseAntonio Ballesta, Laura Orio, Rocío Arco, et al.
Neuropharmacology|March 2, 2019
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressantsPablo Romero-Sanchiz, Raquel Nogueira-Arjona, Antoni Pastor, et al.
Biochemical Pharmacology|September 10, 2018
PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat modelsFrancisco Alen, Juan Decara, Gloria Brunori, et al.
Pageof 2